Search results with tag "Paclitaxel"
DRUG NAME: Paclitaxel, nanoparticle, albumin -bound (nab®)
www.bccancer.bc.caPaclitaxel (the active ingredient of nanoparticle, albumin-bound (nab®) paclitaxel) is an antimicrotubule agent that promotes the assembly and stabilization of microtubules, thus inhibiting normal dynamic reorganization of the microtubule network. Paclitaxel induces abnormal bundles of microtubules throughout the cell cycle and multiple asters ...
DRUG NAME: Paclitaxel - BC Cancer
www.bccancer.bc.caDRUG NAME: Paclitaxel SYNONYM(S): benzenepropanoic acid1. COMMON TRADE NAME(S): TAXOL ®, ONXOL. CLASSIFICATION: antimicrotubule agent. Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Paclitaxel is a taxane.
ANHANG I ZUSAMMENFASSUNG DER MERKMALE DES …
www.ema.europa.eu1. BEZEICHNUNG DES ARZNEIMITTELS Abraxane5mg/ml Pulver zur Herstellung einer Infusionsdispersion. 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG Jede Durchstechflascheenthält 100mg Paclitaxel als an Albumin gebundene Nanopartikel-Formulierung. Jede Durchstechflasche enthält 250mg Paclitaxel als an Albumin gebundene …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eupaclitaxel and carboplatin, is indicated only after failure of appropriate targeted therapies (see section 5.1). Tecentriq, in combination with nab - paclitaxel and carboplatin, is indicated for the first -line treatment of adult patients with metastatic non- squamous NSCLC who do not have EGFR mutant or
Manufacturing and Marketing permission issued from SND ...
cdsco.nic.inS.No. Drug Name Indication Date of Approval 14 Paclitaxel Lipid Suspension for Injection 30mg/vial and 60mg/vial (Additional Dosage Form) 1. Paclitaxel is indicated for the
HIGHLIGHTS OF PRESCRIBING INFORMATION Administer at …
www.gene.comDuring and following paclitaxel, docetaxel, or docetaxel/carboplatin: Initial dose of 4 mg/kg as an intravenous infusion over 90 minutes then at 2 mg/kg as an intravenous infusion over 30 minutes weekly during chemotherapy for the first 12 weeks (paclitaxel or docetaxel) or 18 weeks (docetaxel/carboplatin).
Breast Pathway Group Paclitaxel weekly in Advanced Breast ...
www.londoncanceralliance.nhs.ukBreast Pathway Group – Paclitaxel weekly in Advanced Breast Cancer Version: 1.0 Supersedes: all other versions Approved by LCA Breast Pathway Chemotherapy Lead: Mark Harries November 2014
Peripheral Product Catalog - Medical Technology, …
www.medtronic.com8 IN.PACT™ Admiral™ Drug-Coated Balloon TECHNICAL SPECIFICATIONS Paclitaxel drug dose 3.5 μg/mm2 Excipient Urea Balloon diameters 4 mm - 7 mm Balloon lengths 40, 60, 80, 120, 150 mm*
BC Cancer Protocol Summary for Palliative Therapy …
www.bccancer.bc.caBC Cancer Protocol Summary for Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab (HERCEPTIN), and PACLItaxel as First-Line Treatment for Advanced Breast Cancer
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu2 1. NAME OF THE MEDICINAL PRODUCT Abraxane 5 mg/ml powder for suspension for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 100 mg of paclitaxel formulated as albumin bound nanoparticles.
Protocol: BEP 3-day (Bleomycin/Etoposide/Cisplatin)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 66 Protocol: TIP (Paclitaxel/Ifosfamide/Cisplatin) Indications: Germ cell tumours – Recurrent
DURABLE. CONSISTENT. SAFE. - Medtronic
www.medtronic.comExcipient: Urea Critical component in delivering solid-phase drug to the tissue. Drug: Paclitaxel Proven anti-restenotic drug. IN.PACT™ Admiral™ DCB has proven, long-term durable outcomes across multiple clinical trials, as well as across complex patient and lesion types.
Protocol: AC (Doxorubicin/Cyclophosphamide)
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 19 Protocol: Paclitaxel Indications: Breast Cancer – Adjuvant (high risk), Palliative
DRUG NAME: Paclitaxel, nanoparticle, albumin …
www.bccancer.bc.caThe table includes adverse events that presented during drug treatment but may not necessarily have a causal relationship with the drug. Because clinical trials are conducted under very specific conditions, the adverse event
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
media.celgene.com3 FULL PRESCRIBING INFORMATION ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) WARNING: NEUTROPENIA Do not administer ABRAXANE therapy to patients who have baseline neutrophil counts of less than 1,500 cells/mm3.In order to monitor the occurrence of bone marrow suppression, primarily neutropenia, which
For the Patient Docetaxel injection Other names: TAXOTERE®
www.bccancer.bc.caFor the Patient: Docetaxel injection : Other names: TAXOTERE® Docetaxel (doe-se-TAX-el) is a drug that is used to treat some types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if you have ever had an unusual or allergic reaction to docetaxel, paclitaxel or cabazitaxel before receiving docetaxel.
For Health Professionals Who Care For Cancer Patients
www.bccancer.bc.caCarboplatin and Paclitaxel with Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LULACATRT) – A new chemoradiation regimen for patients with locally advanced non-small cell lung cancer (NSCLC) is now available. It is an alternative to the existing cisplatin and etoposide protocols
Pharmaceutical Dosage Forms - Temple University
pharmacy.temple.eduAlbumin-bound nanoparticles 200 nm Nanocrystals Nanogels Cubosomes Liposome Functionaized SL solid-lipid nanoparticles Paclitaxel FIGURE 12.1 (See color insert.) Approximate size spectrum showing dimensions of typical molecules, carrier types, and drug delivery systems based on the published literature and some of the commercialized
BC Cancer Protocol Summary for Primary Treatment of No ...
www.bccancer.bc.cab) at nadir (until nadir pattern established): ANC (x 109/L) Platelets (x 109/L) PACLItaxel CARBOplatin* greater than or equal to 1.5 and greater than or equal to 100 100% 120%** 0.5-1.4 and greater than or equal to 75 100% 100%
Page 1 of 4 Paclitaxel Albumin (Abraxane®) and Gemcitabine ...
www.londoncanceralliance.nhs.ukRepeat FBC, if recovered to above these levels, resume treatment at full dose. Consider dose reduction for >1 delay.
Protocol: Carboplatin/Paclitaxel - Mid-Western Cancer Centre
www.midwesterncancercentre.ieDepartment of Medical Oncology Chemotherapy Protocols 3rd Edition 60 Protocol: PMB (Cisplatin/Methotrexate/Bleomycin) Indications: Cervix Cancer – Advanced, Recurrent
For the Patient Paclitaxel - BC Cancer
www.bccancer.bc.ca(pak'' li tax' el) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein.
CANCER DRUG PHARMACOLOGY TABLE
www.bccancer.bc.capaclitaxel (regular and nanoparticle, albumin-bound) (taxane) vinblastine (vinca alkaloid) vincristine (vinca alkaloid) ... The last letters in the drug names in the table provide information about the classification of the drug: - mab = monoclonal antibody - zomib = proteasome inhibitor
NCCN Clinical Practice Guidelines in Oncology NCCN ...
www2.tri-kobe.orgCarboplatin + albumin-bound paclitaxel + atezolizumab as an "other recommended" treatment option as a category 2A. Nivolumab + ipilimumab as an "other recommended" treatment option as a category 2A. NSCL-J 3 of 4 • The following treatment options added for patients with metastatic squamous cell NSCLC, PD-L1 <1%, and PS 0-1.
1 非劣性試験 - chugaiigaku.jp
www.chugaiigaku.jpAlbumin ≦3.5/＞3.5 g/dl Institution IP＊ Cisplatin 80 mg/m2, day1 Irinotecan 60 mg/m2, days1, 8, 15 every 4 weeks TC Carboplatin AUC 6, day1 Paclitaxel 200 mg/m2, day1 every 3 weeks GPCisplatin 80 mg/m2, day1 Gemctitabine 1 g/m, days1, 8 every 3 weeks ... 1．非劣性試験 4 1-1）．本試験の統計学的考察は以下のような ...
NEW ZEALAND DATA SHEET - Medsafe
medsafe.govt.nzAvastin (bevacizumab) in combination with carboplatin and paclitaxel is indicated for the treatment of patients with recurrent, platinum-sensitive, epithelial ovarian, fallopian tube, or
Similar queries
Paclitaxel, Albumin, Drug, Carboplatin, Manufacturing and Marketing permission issued, PRESCRIBING INFORMATION, Paclitaxel weekly, Version, Product Catalog, Coated Balloon, Balloon, BC Cancer, Breast Cancer, NAME, Protocol, 3-day Bleomycin/Etoposide/Cisplatin, Medtronic, Protocol: AC Doxorubicin/Cyclophosphamide, Treatment, ABRAXANE, Docetaxel, For Health Professionals Who Care For Cancer, PACLItaxel CARBOplatin, 1 of 4 Paclitaxel Albumin, Protocol: Carboplatin/Paclitaxel, CANCER DRUG PHARMACOLOGY TABLE, NEW ZEALAND DATA SHEET